SEC Form 4 · accession 0001385508-18-000063
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas T. Thomas
Director
Period of report
Jun 13, 2018
Accepted (ET)
Jun 14, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.56 | Jun 13, 2018 | A | 2,500 | A | Jun 13, 2019 | Jun 13, 2028 | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1On June 13, 2018, the reporting person was granted 2,500 non-qualified stock options. 100% of these options vest on the one year anniversary of the grant date.